about
Therapeutic efficacy and biodistribution of allogeneic mesenchymal stem cells delivered by intrasplenic and intrapancreatic routes in streptozotocin-induced diabetic mice.Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patientsMitochondrial DNA Activates the NLRP3 Inflammasome and Predisposes to Type 1 Diabetes in Murine ModelXenogeneic Mesenchymal Stromal Cells Improve Wound Healing and Modulate the Immune Response in an Extensive Burn Model.Salivary anti-PGL-1 IgM may indicate active transmission of Mycobacterium leprae among young people under 16 years of age.Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties.Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells enhances the recruitment of CD11b(+) myeloid cells to the lungs and facilitates B16-F10 melanoma colonization.Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice
P50
Q35609423-DE0CB15C-6464-428F-BD4E-1C51C676163EQ37089931-E025B140-4AC0-48D6-BE1B-199A84C1D78BQ37667286-3D6FB12F-B52E-4A72-953A-4D3A85D0A337Q39009452-1727A340-0ED9-47F9-9DF3-2B7440F7EA1EQ40177423-48837F3A-18BF-497D-B00F-B92A510F10A3Q41196008-D4435370-942B-4017-BB51-F64CF1A3D733Q53486125-52C87FB0-1ED8-48EA-A8E1-0B657A3BF466Q58855536-FFD8D79D-BF6E-4DAE-9FFD-108970C8331E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Juliana N U Yaochite
@en
Juliana N U Yaochite
@nl
type
label
Juliana N U Yaochite
@en
Juliana N U Yaochite
@nl
prefLabel
Juliana N U Yaochite
@en
Juliana N U Yaochite
@nl
P108
P31
P496
0000-0002-9666-5992